Cytogenetic and immunohistochemical biomarker profiling of therapy‐relevant factors in salivary gland carcinomas

J Lemound, M Schenk, G Keller… - Journal of Oral …, 2016 - Wiley Online Library
Objectives There is currently no established algorithm for the molecular profiling of therapy‐
relevant defects in salivary gland carcinomas (SGC). HER 2 overexpression in a subfraction …
被引用次数：12 相关文章

Cytogenetic and immunohistochemical biomarker profiling of therapy-relevant factors in salivary gland carcinomas

J Lemound, M Schenk, G Keller… - Journal of Oral …, 2016 - hero.epa.gov
OBJECTIVES: There is currently no established algorithm for the molecular profiling of
therapy-relevant defects in salivary gland carcinomas (SGC). HER2 overexpression in a …

Cytogenetic and immunohistochemical biomarker profiling of therapy-relevant factors in salivary gland carcinomas

J Lemound, M Schenk, G Keller… - Journal of oral …, 2016 - pubmed.ncbi.nlm.nih.gov
Objectives There is currently no established algorithm for the molecular profiling of therapy-
relevant defects in salivary gland carcinomas (SGC). HER2 overexpression in a subfraction …

Cytogenetic and immunohistochemical biomarker profiling of therapy-relevant factors in salivary gland carcinomas.

J Lemound, M Schenk, G Keller… - Journal of Oral …, 2016 - europepmc.org
Objectives There is currently no established algorithm for the molecular profiling of therapy-
relevant defects in salivary gland carcinomas (SGC). HER2 overexpression in a subfraction …

Cytogenetic and immunohistochemical biomarker profiling of therapy‐relevant factors in salivary gland carcinomas

J Lemound, M Schenk, G Keller, A Stucki‐Koch… - Journal of Oral …, 2016 - infona.pl
Objectives There is currently no established algorithm for the molecular profiling of therapy‐
relevant defects in salivary gland carcinomas (SGC). HER 2 overexpression in a subfraction …